# Kaltura, Inc.

Type: Company (KLTR)

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/kaltura-inc
Canonical HTML page: https://gethealthbrief.com/entity/kaltura-inc

## Recent coverage (1 stories)

### Kaltura and Longeveron Q4 Reports Highlight Health IT Pivot and Biotech Strain
2026-03-19 13:47:31 · Sentiment: Neutral · Impact: 5/10 · Sources: 4

Kaltura reports Q4 2025 results as it deepens its footprint in healthcare video solutions, while Longeveron faces listing challenges despite clinical progress with its Lomecel-B therapy. The dual reports underscore the diverging paths of established Health IT infrastructure versus high-risk clinical stage biotechnology.
Full story: https://gethealthbrief.com/story/kaltura-longeveron-q4-2025-earnings-analysis

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.